BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36918828)

  • 1. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
    Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
    BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application and clinical significance of TCGA molecular classification in endometrial cancer].
    Zhao LY; Dai YB; Li LW; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):697-704. PubMed ID: 34823319
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers.
    Li Y; Feng J; Zhao C; Meng L; Shi S; Liu K; Ma J
    Ann Transl Med; 2022 Aug; 10(16):870. PubMed ID: 36111057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M; Zhao L; Shen D; Li X; Wang J; Wei L
    Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
    Du NN; Liu Y; Ren CX; Wang YX; Du J; Yang J; Liu CR
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):596-603. PubMed ID: 31422589
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.
    Willvonseder B; Stögbauer F; Steiger K; Jesinghaus M; Kuhn PH; Brambs C; Engel J; Bronger H; Schmidt GP; Haller B; Weichert W; Keller G; Noske A; Pfarr N; Boxberg M
    Cancer Immunol Immunother; 2021 Jun; 70(6):1679-1689. PubMed ID: 33340331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods.
    Bayramoglu D; Seçilmiş Kerimoğlu Ö; Bayramoğlu Z; Çintesun E; Şahin G; Karabağlı P; Çelik Ç
    Ginekol Pol; 2023; 94(1):3-11. PubMed ID: 35072228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma.
    Travaglino A; Raffone A; Mollo A; Borrelli G; Alfano P; Zannoni GF; Insabato L; Zullo F
    Arch Gynecol Obstet; 2020 May; 301(5):1117-1125. PubMed ID: 32253551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
    Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
    Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study.
    Moreira I; Bartosch C; Teixeira M; Ferreira M
    JMIR Res Protoc; 2022 Aug; 11(8):e34461. PubMed ID: 35925678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
    Travaglino A; Raffone A; Stradella C; Esposito R; Moretta P; Gallo C; Orlandi G; Insabato L; Zullo F
    Arch Gynecol Obstet; 2020 Jun; 301(6):1355-1363. PubMed ID: 32296930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
    Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
    World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.
    He D; Wang H; Dong Y; Zhang Y; Zhao J; Lv C; Zheng X; Li D; Li T
    Gynecol Oncol; 2020 Oct; 159(1):36-42. PubMed ID: 32800323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis.
    He Y; Wang T; Li N; Yang B; Hu Y
    Medicine (Baltimore); 2020 Feb; 99(8):e19281. PubMed ID: 32080141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.